Salisbury Franklin Cary jr 4
4 · CASI Pharmaceuticals, Inc. · Filed Jun 18, 2020
Insider Transaction Report
Form 4
Salisbury Franklin Cary jr
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2020-06-16+68,800→ 68,800 totalExercise: $2.63Exp: 2030-06-16→ Common Stock (68,800 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of the year.
Signature
/s/ Cynthia W. Hu, attorney-in-fact for Franklin C. Salisbury, Jr.|2020-06-17